Tag: Akkadian
Phaxiam Therapeutics (formerly Erytech): Akkadian Partners takes legal action – 07/04/2023 at 11:06
(AOF) – The activist fund Akkadian Partners, opposed to the merger between Erytech and Pherecydes (which gave birth to Phaxiam Therapeutics), indicates that it has kept all the shares it…
Erytech: Akkadian does not intend to participate in the GA
(CercleFinance.com) – Akkadian said Thursday that he did not intend to participate in Erytech’s general meeting to be held tomorrow to allow shareholders to vote on the proposed merger with…
ERYTECH announces that Akkadian is continuing its destabilization attempt with the introduction of a new legal action – 06/20/2023 at 22:05
PRESS RELEASE ERYTECH announces that Akkadian continues its attempt at destabilization with the introduction of a new legal action Lyon (France), June 20, 2023 – ERYTECH Pharma (Euronext Paris and…
ERYTECH announces that Akkadian is continuing its destabilization attempt with the introduction of a new legal action – 06/20/2023 at 22:05
Despite the rejection by the President of the Commercial Court of Lyon of Akkadian Partners’ request to postpone the vote of the general meeting on the proposed merger, Akkadian has…
Pherecydes Pharma / Erytech: the TC of Lyon dismisses Akkadian
By Alexandra Saintpierre Published on 06/14/2023 at 9:38 p.m. Photo credit © Erytech (Boursier.com) — The biotechnology company…
Erytech: Akkadian Partners accuses managers of liquidation blackmail – 06/13/2023 at 11:26
(AOF) – Akkadian Partners “says no to the liquidation of Erytech in the event of failure of the merger with Pherecydes”. “It’s a scandal” continues the activist fund, to impose…
Erytech: defends the Pherecydes project, accuses Akkadian – 06/12/2023 at 14:30
(CercleFinance.com) – Erytech on Monday accused the Akkadian investment fund of conducting a disinformation campaign against it by contesting its proposed merger with Pherecydes on the basis in particular of…
Erytech: Akkadian offers an alternative strategy – 06/07/2023 at 14:39
(CercleFinance.com) – The investment fund Akkadian Partners pleaded on Wednesday for an alternative strategy for Erytech, considering that the proposed merger with Pherecydes underestimated the value of biotech. Akkadian believes…
Pherecydes announces that legal proceedings have been initiated against Erytech by Akkadian to obtain the postponement of the vote on the merger with Pherecydes – 06/05/2023 at 08:00
Nantes, June 5, 2023 – 8:00 a.m. CEST – Pherecydes Pharma (FR0011651694 – ALPHE, PEA-PME eligible), a biotechnology company specializing in phage therapy intended to treat antibiotic-resistant and/or complicated bacterial…
ERYTECH announces that Akkadian has initiated a procedure aimed at obtaining the postponement of the vote on the merger with Pherecydes – 06/05/2023 at 08:00
PRESS RELEASE ERYTECH announces that Akkadian has initiated a procedure to obtain the postponement of the vote of the merger with Pherecydes Lyon (France), June 5, 2023 – ERYTECH Pharma…
ERYTECH announces that Akkadian has initiated a procedure aimed at obtaining the postponement of the vote on the merger with Pherecydes – 06/05/2023 at 08:00
If you wish to receive all of the company’s financial communications in real time, you can register directly by email at the following address: [email protected] ERYTECH Pharma (Euronext Paris and…
Erytech: the Akkadian Partners fund denounces an “abuse of power” by managers – 05/19/2023 at 11:09
(AOF) – Akkadian Partners, new shareholder of Erytech and opponent of the merger of biotech with the company Pherecydes, denounces in a press release published today a “characterised abuse of…